<DOC>
	<DOCNO>NCT02966899</DOCNO>
	<brief_summary>The goal study elucidate relationship myocardial right ventricular triglyceride content ( steatosis ) right ventricular dysfunction participant pulmonary hypertension , investigate reversibility phenotype omega-3 fatty acid treatment .</brief_summary>
	<brief_title>Reversal Right Ventricular Steatosis Pulmonary Hypertension</brief_title>
	<detailed_description>The investigator propose treat 30 participant identify elevated myocardial triglyceride content ( define great 0.50 % ) cardiac MRI 4 gram omega-3 fatty acid daily six month primary end point reduce right ventricular steatosis secondary endpoint improve RV systolic function . The investigator hypothesize right ventricular steatosis cardiac MRI associate degree right ventricular systolic function cardiac MRI . In subset participant elevate baseline steatosis treat lipoprotective strategy , investigator hypothesize six month therapy omega-3 fatty acid reduce myocardial steatosis improve right ventricular systolic function .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Adult men woman &gt; 30 year age diagnosis pulmonary hypertension ( define mean pulmonary arterial pressure â‰¥25 mmHg rest right heart catheterization ) Contraindication MRI ( e.g. , metallic hazard allergy gadolinium ) Renal dysfunction ( eGFR &lt; 60 ml/min/1.73m2 estimate Modified Diet Renal Disease formula ) High risk feature nephrogenic systemic fibrosis ( solitary kidney prior renal transplant ) Active pregnancy breastfeeding ( determined urinary pregnancy test CMR ) Weight &gt; 550 lb waist diameter &gt; 70 cm ( limit Siemens Verio CMR system ) Fish Allergy</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>